287 related articles for article (PubMed ID: 18924154)
21. Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-up.
Krappmann P; Paulides M; Stöhr W; Ittner E; Plattig B; Nickel P; Lackner H; Schrappe M; Janka G; Beck JD; Langer T
Pediatr Hematol Oncol; 2007 Mar; 24(2):101-9. PubMed ID: 17454775
[TBL] [Abstract][Full Text] [Related]
22. Childhood acute lymphoblastic leukemia: current perspectives.
Landier W
Oncol Nurs Forum; 2001 Jun; 28(5):823-33; quiz 834-5. PubMed ID: 11421142
[TBL] [Abstract][Full Text] [Related]
23. Acute lymphoblastic leukemia: current treatment concepts.
Arya LS
Indian Pediatr; 2000 Apr; 37(4):397-406. PubMed ID: 10781233
[No Abstract] [Full Text] [Related]
24. Late effects in long-term survivors after treatment for childhood acute leukemia.
Haddy TB; Mosher RB; Reaman GH
Clin Pediatr (Phila); 2009 Jul; 48(6):601-8. PubMed ID: 19264722
[TBL] [Abstract][Full Text] [Related]
25. Interventions to improve neuropsychological functioning in childhood cancer survivors.
Butler RW; Sahler OJ; Askins MA; Alderfer MA; Katz ER; Phipps S; Noll RB
Dev Disabil Res Rev; 2008; 14(3):251-8. PubMed ID: 18924157
[TBL] [Abstract][Full Text] [Related]
26. A meta-analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia.
Peterson CC; Johnson CE; Ramirez LY; Huestis S; Pai AL; Demaree HA; Drotar D
Pediatr Blood Cancer; 2008 Jul; 51(1):99-104. PubMed ID: 18322925
[TBL] [Abstract][Full Text] [Related]
27. The cerebellar mutism syndrome and its relation to cerebellar cognitive function and the cerebellar cognitive affective disorder.
Wells EM; Walsh KS; Khademian ZP; Keating RF; Packer RJ
Dev Disabil Res Rev; 2008; 14(3):221-8. PubMed ID: 18924161
[TBL] [Abstract][Full Text] [Related]
28. Negative correlation between cerebrospinal fluid tau protein and cognitive functioning in children with acute lymphoblastic leukemia.
Protas PT; Muszynska-Roslan K; Holownia A; Grabowska A; Wielgat P; Krawczuk-Rybak M; Braszko JJ
Pediatr Blood Cancer; 2009 Jul; 53(1):105-8. PubMed ID: 19309718
[TBL] [Abstract][Full Text] [Related]
29. Inherited disorders as a risk factor and predictor of neurodevelopmental outcome in pediatric cancer.
Ullrich NJ
Dev Disabil Res Rev; 2008; 14(3):229-37. PubMed ID: 18924162
[TBL] [Abstract][Full Text] [Related]
30. Sex-specific attention problems in long-term survivors of pediatric acute lymphoblastic leukemia.
Jain N; Brouwers P; Okcu MF; Cirino PT; Krull KR
Cancer; 2009 Sep; 115(18):4238-45. PubMed ID: 19536898
[TBL] [Abstract][Full Text] [Related]
31. Comparison of long-term neurocognitive outcomes in young children with acute lymphatic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Cohen IJ
J Clin Oncol; 2007 Feb; 25(6):734-5; author reply 735. PubMed ID: 17308283
[No Abstract] [Full Text] [Related]
32. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal psychosocial outcomes in two cohorts of adult survivors from childhood acute leukemia treated with or without cranial radiation.
Massimo LM; Wiley TJ; Bonassi S; Caprino D
Minerva Pediatr; 2006 Feb; 58(1):1-7. PubMed ID: 16541001
[TBL] [Abstract][Full Text] [Related]
34. Folate homeostasis in cerebrospinal fluid during therapy for acute lymphoblastic leukemia.
Cole PD; Beckwith KA; Vijayanathan V; Roychowdhury S; Smith AK; Kamen BA
Pediatr Neurol; 2009 Jan; 40(1):34-41. PubMed ID: 19068252
[TBL] [Abstract][Full Text] [Related]
35. Pediatric acute lymphoblastic leukemia: redefining outcomes.
Kadan-Lottick N; Neglia JP
J Pediatr Hematol Oncol; 2002 Feb; 24(2):88. PubMed ID: 11990711
[No Abstract] [Full Text] [Related]
36. Neuropsychological impact of treatment of brain tumors.
De Luca CR; Conroy R; McCarthy MC; Anderson VA; Ashley DM
Cancer Treat Res; 2009; 150():277-96. PubMed ID: 19834674
[No Abstract] [Full Text] [Related]
37. Neurocognitive outcome in survivors of pediatric cancer.
Winick N
Curr Opin Pediatr; 2011 Feb; 23(1):27-33. PubMed ID: 21157347
[TBL] [Abstract][Full Text] [Related]
38. Late effects risk profiles using the long-term follow-up guidelines in identical twin survivors of acute lymphoblastic leukemia.
Howell DL; Lew G; Comeaux LG; Meacham LR
Pediatr Blood Cancer; 2007 Sep; 49(3):349-52. PubMed ID: 16602119
[TBL] [Abstract][Full Text] [Related]
39. P300 as indicator of effects of prophylactic cranial radiation.
Sato T; Miyao M; Muchi H; Gunji Y; Iizuka A; Yanagisawa M
Pediatr Neurol; 1992; 8(2):130-2. PubMed ID: 1580956
[TBL] [Abstract][Full Text] [Related]
40. The relationship between cognitive and neuroimaging outcomes in children treated for acute lymphoblastic leukemia with chemotherapy only: A systematic review.
Hearps S; Seal M; Anderson V; McCarthy M; Connellan M; Downie P; De Luca C
Pediatr Blood Cancer; 2017 Feb; 64(2):225-233. PubMed ID: 27696698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
